...
首页> 外文期刊>Journal of Medicinal Chemistry >Stereoselective chemoenzymatic synthesis of the four stereoisomers of L-2-(2-carboxycyclobutyl)glycine and pharmacological characterization at human excitatory amino acid transporter subtypes 1, 2, and 3
【24h】

Stereoselective chemoenzymatic synthesis of the four stereoisomers of L-2-(2-carboxycyclobutyl)glycine and pharmacological characterization at human excitatory amino acid transporter subtypes 1, 2, and 3

机译:L-2-(2-羧基环丁基)甘氨酸的四种立体异构体的立体选择性化学酶法合成及人兴奋性氨基酸转运蛋白亚型1、2和3的药理学表征

获取原文
获取原文并翻译 | 示例

摘要

The four stereoisomers of L-2-(2-carboxycyclobutyl) glycine, L-CBG-I, L-CBG-II, L-CBG-III, and L-CBG-IV, were synthesized in good yield and high enantiomeric excess, from the corresponding cis and trans-2-oxalylcyclobutanecarboxylic acids 5 and 6 using the enzymes aspartate aminotransferase (AAT) and branched chain aminotransferase (BCAT) from Escherichia coli. The four stereoisomeric compounds were evaluated as potential ligands for the human excitatory amino acid transporters, subtypes 1, 2, and 3 (EAAT1, EAAT2, and EAAT3) in the FLIPR membrane potential assay. While the one trans-stereoisomer, L-CBG-I, displayed weak substrate activity at all three transporters, EAAT1-3, we found a particular pharmacological profile for the other trans-stereoisomer, L-CBG-II, which displayed EAAT1 substrate activity and inhibitory activity at EAAT2 and EAAT3. Whereas L-CBG-III was found to be a weak inhibitor at all three EAAT subtypes, the other cis-stereoisomer L-CBG-IV was a moderately potent inhibitor with 20-30-fold preference for EAAT2/3 over EAAT1.
机译:合成了L-2-(2-羧基环丁基)甘氨酸的四种立体异构体L-CBG-I,L-CBG-II,L-CBG-III和L-CBG-IV,其收率高且对映体过量,使用来自大肠杆菌的天冬氨酸氨基转移酶(AAT)和支链氨基转移酶(BCAT)从相应的顺式和反式-2-草酰环丁烷羧酸5和6中提取。在FLIPR膜电位测定法中,将这四种立体异构体化合物评估为人类兴奋性氨基酸转运蛋白亚型1、2和3(EAAT1,EAAT2和EAAT3)的潜在配体。尽管一个反式立体异构体L-CBG-I在所有三个转运蛋白EAAT1-3上均显示较弱的底物活性,但我们发现另一种反式立体异构体L-CBG-II表现出了EAAT1底物活性的特殊药理学特征以及对EAAT2和EAAT3的抑制活性。尽管发现L-CBG-III是所有三种EAAT亚型的弱抑制剂,但另一种顺式立体异构体L-CBG-IV是中等有效的抑制剂,相对于EAAT1,其对EAAT2 / 3的偏爱为20-30倍。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号